TotalMarketCap

Korro Bio

KRRONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$219.265 M

$14.89 -10.41%

Close of 6 Nov 2026

As of 6 Nov 2026, Korro Bio (KRRO) has a market capitalization of $219.3M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$6.39M

#3221 by revenue

Earnings

-$117.3M

Loss-making

Shares outstanding

13,725,646

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #236Camp4 TherapeuticsCAMP$233.4M
  2. #237Abeona TherapeuticsABEO$224.4M
  3. #238Korro BioKRRO$219.3M
  4. #239ImmuneeringIMRX$217.9M
  5. #240Vanda PharmaceuticalsVNDA$217.7M

What if Korro Bio were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,917,530

Per share 128,780× higher

Bitcoin $1.53T

$103,754.23

Per share 6,968× higher

Apple $5.02T

$340,615.46

Per share 22,875× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Korro Bio are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.